Bell Rock Capital’s VivoSim Labs VIVS Stock Holding History

Bell Rock Capital’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1	Closed	–	–	432
2017 Q3	$0	Hold	1	–	–	﹤0.01%	435
2017 Q2	$1K	Buy	+1	New	+$672	﹤0.01%	414

Other funds holding VIVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bell Rock Capital's VIVS Position: Q4 2017 in Review

Bell Rock Capital sold out of VivoSim Labs (VIVS) in Q4 2017, closing a stake of 1 share.

Bell Rock Capital first reported a position in VIVS in Q2 2017 and held it in 2 quarters. The position peaked at $1K in Q2 2017. 123 funds tracked by Wall St. Rank hold VIVS as of Q4 2017.

Bell Rock Capital reported no remaining VivoSim Labs position as of Q4 2017 after selling out during the quarter.
Bell Rock Capital sold 1 VivoSim Labs share in Q4 2017.
Bell Rock Capital first reported a position in VivoSim Labs in Q2 2017 and held it in 2 quarters.
Bell Rock Capital's VivoSim Labs position peaked at $1K in Q2 2017.
123 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2017.

Based on Bell Rock Capital's 13F filing for Q4 2017, filed 13 Nov 2018.